Premium
Global rosacea treatment guidelines and expert consensus points: The differences
Author(s) -
Juliandri Juliandri,
Wang Xiaoyan,
Liu Zijing,
Zhang Jiawen,
Xu Yang,
Yuan Chao
Publication year - 2019
Publication title -
journal of cosmetic dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.626
H-Index - 44
eISSN - 1473-2165
pISSN - 1473-2130
DOI - 10.1111/jocd.12903
Subject(s) - rosacea , medicine , dermatology , papulopustular , clinical trial , randomized controlled trial , guideline , observational study , demodex , surgery , pathology , botany , acne , biology , mite
Summary Background Rosacea is a highly prevalent, chronic inflammatory disease. The treatment of rosacea remains a challenge to dermatologists. Therapies include skin care, medications, lasers, and various combinations of these modalities. The appropriate treatment depends on clinical types and patient's various clinical symptoms. Purpose The purpose of this study was to review and compare current therapies for rosacea of all severities from four different guidelines. Methodology We searched PubMed using the keywords “rosacea,” “treatment” AND [“erythema rosacea” OR “papulopustular rosacea” OR “ocular rosacea” OR “phymatous rosacea”]. We selected randomized controlled trials, observational studies, controlled clinical trials, and clinical trials. We indentified further studies (including the guidelines) by hand‐searching relevant publications and included those that met the inclusion criteria. Results The total number of records identified was 421. We limited our search to the specific abovementioned study types. Twenty‐five of these studies met with our inclusion criteria. An additional five manuscripts were selected using the abovementioned method, and four guidelines were included in this review. Conclusion Diagnosing and choosing the appropriate treatment options of rosacea according to guidelines is the basis of scientific criteria. More large‐scale randomized controlled clinical trials on new treatment methods, new drugs, or new dosage forms provide a new guideline for future rosacea treatment. Although there are some differences in the treatment of rosacea, it is generally based on anti‐demodex, anti‐inflammatory, and anti‐angiogenesis.